Available Until 9/20/2022

Pediatric Pharmacy Specialty Core Therapeutic Module Package for Recertification (Cert # L219215)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 09/01/2021
Content Release Date: 09/22/2021
Expiration Date: 09/20/2022
Activity Type: Application-based
CE Credits: 3.0 (BPS and ACPE) contact hours
Activity Fee: $100 (ASHP member); $150 (non-member)

Activity Overview

The Core Therapeutic Modules for Recertification Package consists of 3 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS).

Each activity is approved for 1.0 contact hour of continuing pharmacy education credit. Successful completion of all the learning modules will provide up to 3.0 contact hours of continuing pharmacy education credit.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  

These activities are intended for Board Certified Pediatric Pharmacy Specialists in need of recertification credit. 

Board certified pharmacists are eligible to receive 3.0 contact hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessment by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Participants who pass the assessments will be eligible for recertification credit in the year in which the assessment was completed.

These activities are part of the ASHP professional development program for BCPPS recertification approved by the BPS.  

ACPE Number

Learning Module

Contact Hours

*Assessment Pass Point

0204-0000-21-607-H01-P

Select Topics in Pediatric Critical and Emergency Care

1

77%

0204-0000-21-608-H01-P

Select Topics in Pediatric Hematology / Oncology

1

0204-0000-21-609-H01-P

Select Topics in Pediatric Neurology and Psychiatry Part 1

1

After participating in these CPE activities, learners should be able to:

Select Topics in Pediatric Critical and Emergency Care   
ACPE #:0204-0000-21-607-H01-P

  • Interpret diagnostic and/or laboratory tests, vital signs, and clinical presentation of a pediatric patient with traumatic brain injury or select toxicological emergencies (e.g., acetaminophen, ethylene glycol).
  • Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines.
  • Develop appropriate medication dosing plans for a pediatric patient on ECMO.
  • Develop plans to manage underlying disorders.

Select Topics in Pediatric Hematology / Oncology              
ACPE #:0204-0000-21-608-H01-P

  • Interpret signs, symptoms and diagnostic tests for chemotherapy-induced nausea and vomiting, mucositis, immune thrombocytopenia, infantile hemangioma, and palliative care in pediatric cancer patients
  • Evaluate patient information to identify drug-related problems and response to therapy.
  • Identify appropriate modifications and supportive care plans based on patient-specific follow up assessment.

Select Topics in Pediatric Neurology and Psychiatry Part 1           
ACPE #:0204-0000-21-609-H01-P

  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with migraines, autism, cerebral palsy, depression or anxiety.
  • Evaluate patients for drug-related problems and response to therapy.
  • Identify appropriate modifications of patient-specific treatment plans based on follow up assessment.

Faculty bios

Lea Eiland, Pharm.D., BCPS, BCPPS, FASHP, FPPAG
Clinical Professor and Associate Department Head
Auburn University Harrison School of Pharmacy
Auburn, Alabama

Katie Hughes, Pharm.D., BCPPS
Clinical Pharmacist Pediatric Critical Care
Riley Hospital for Children at IU Health
Indianapolis, Indiana

Peter N. Johnson, Pharm.D., BCPPS, BCPS, FCCM, FPPAG*
Associate Professor of Pharmacy Practice
University of Oklahoma College of Pharmacy
Clinical Pharmacy Specialist--Pediatric Critical Care
The Children's Hospital at OU Medical Center
Oklahoma City, Oklahoma

Kate Reichert, Pharm.D., BCPPS
Pediatric Oncology Clinical Pharmacy Specialist
Department of Pharmacy
Memorial Sloan Kettering Cancer Center
New York, New York

Jennifer L. Thackray, Pharm.D., BCPPS, BCPS*
Pediatric Oncology Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York

*Content Matter Experts

Michelle Abalos, Pharm.D.
Kristi Hofer, Pharm.D.

Amy Alonzo, Pharm.D., BCPPS
Michelle Barrie, Pharm.D., BCPPS
Vaibhavi Bhavsar, Pharm.D.
Jacklyn Bradley, Pharm.D.
Octavio Casanova, Pharm.D., BCPPS
Kimberly Cheng, Pharm.D., BCPPS
Melissa Cook, Pharm.D., BCPPS
Nozomi Giese Kim, Pharm.D., BCPS, BCPPS
Eok Jun, Pharm.D.,BCPPS
Ekaterina Kurdyukova, Pharm.D., BCPPS
Erin Munsel, Pharm.D., BCPPS
Lane Nguyen, Pharm.D., BCPPS
Leslie Patatanian, B.S., Pharm.D., BCPPS
Stephanie Pennington, Pharm.D., BCPPS
Elizabeth Shober, Pharm.D., BCPPS
Anna Simmont, Pharm.D., BCPS, BCPPS
Sadie Stone, Pharm.D., BCPPS
Leslie Thompson, Pharm.D., BCPS, BCPPS
Susan Villegas, Pharm.D., BCPPS
Carol Vollmer-Johnson, Pharm.D., BCPPS

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. 

All planners, presenters, and reviewers of this session report no financial relationships relevant to this activity. 

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

Development

These activities were developed by ASHP.